BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34990887)

  • 21. Trimethylamine N-Oxide Aggravates Liver Steatosis through Modulation of Bile Acid Metabolism and Inhibition of Farnesoid X Receptor Signaling in Nonalcoholic Fatty Liver Disease.
    Tan X; Liu Y; Long J; Chen S; Liao G; Wu S; Li C; Wang L; Ling W; Zhu H
    Mol Nutr Food Res; 2019 Sep; 63(17):e1900257. PubMed ID: 31095863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between 12α-hydroxylated bile acids and hepatic steatosis in rats fed a high-fat diet.
    Hori S; Abe T; Lee DG; Fukiya S; Yokota A; Aso N; Shirouchi B; Sato M; Ishizuka S
    J Nutr Biochem; 2020 Sep; 83():108412. PubMed ID: 32534424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of cholesterol and bile acid homeostasis by the cholesterol 7α-hydroxylase/steroid response element-binding protein 2/microRNA-33a axis in mice.
    Li T; Francl JM; Boehme S; Chiang JY
    Hepatology; 2013 Sep; 58(3):1111-21. PubMed ID: 23536474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.
    Liu H; Pathak P; Boehme S; Chiang JL
    J Lipid Res; 2016 Oct; 57(10):1831-1844. PubMed ID: 27534992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of cholesterol 7α-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis.
    Li T; Matozel M; Boehme S; Kong B; Nilsson LM; Guo G; Ellis E; Chiang JY
    Hepatology; 2011 Mar; 53(3):996-1006. PubMed ID: 21319191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 25-Hydroxycholesterol activates the expression of cholesterol 25-hydroxylase in an LXR-dependent mechanism.
    Liu Y; Wei Z; Ma X; Yang X; Chen Y; Sun L; Ma C; Miao QR; Hajjar DP; Han J; Duan Y
    J Lipid Res; 2018 Mar; 59(3):439-451. PubMed ID: 29298812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
    Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
    Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice.
    Zheng N; Wang H; Zhu W; Li Y; Li H
    J Ethnopharmacol; 2024 Feb; 320():117401. PubMed ID: 37967775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loperamide induces excessive accumulation of bile acids in the liver of mice with different diets.
    Lei Z; Rong H; Yang Y; Yu S; Zhang T; Chen L; Nie Y; Song Q; Hu Q; Guo J
    Toxicology; 2022 Jul; 477():153278. PubMed ID: 35926757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ablation of gut microbiota alleviates obesity-induced hepatic steatosis and glucose intolerance by modulating bile acid metabolism in hamsters.
    Sun L; Pang Y; Wang X; Wu Q; Liu H; Liu B; Liu G; Ye M; Kong W; Jiang C
    Acta Pharm Sin B; 2019 Jul; 9(4):702-710. PubMed ID: 31384531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
    Front Immunol; 2020; 11():148. PubMed ID: 32158445
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholesterol 25-hydroxylase protects against experimental colitis in mice by modulating epithelial gut barrier function.
    Sheng N; Ma Z; Zhou Y; Xu J; Gao Y; Fu XY
    Sci Rep; 2020 Aug; 10(1):14246. PubMed ID: 32859970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
    Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
    J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of brewers' spent grain on high-fat diet-induced fatty liver.
    Pei Y; Balogun O; Otieno D; Parks JS; Kang HW
    Biochem Biophys Res Commun; 2022 Aug; 616():49-55. PubMed ID: 35636255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymethoxyflavones in citrus extract has a beneficial effect on hypercholesterolemia rats by promoting liver cholesterol metabolism.
    Du Y; Su J; Yan M; Wang Q; Wang T; Gao S; Tian Y; Wang Y; Chen S; Lv G; Yu J
    J Ethnopharmacol; 2024 Mar; 322():117644. PubMed ID: 38135227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Houttuynia cordata alleviates high-fat diet-induced non-alcoholic fatty liver in experimental rats.
    Kang H; Koppula S
    Pharm Biol; 2015 Mar; 53(3):414-22. PubMed ID: 25272018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.
    Qi Y; Jiang C; Cheng J; Krausz KW; Li T; Ferrell JM; Gonzalez FJ; Chiang JY
    Biochim Biophys Acta; 2015 Jan; 1851(1):19-29. PubMed ID: 24796972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
    Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
    J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.